GLP-1 Peptide Hub

Every GLP-1 guide on PeptideStack, in one place. Research-compound coverage (retatrutide and the next incretins), approved-medication guides (Ozempic, tirzepatide, Zepbound), head-to-head comparisons, telehealth program reviews, and free calculators — organized so you can follow a topic end to end instead of hunting through the blog.

Approved GLP-1 medications require a prescription. Research compounds are sold for laboratory research only and are not for human use. Nothing here is medical advice.

Retatrutide & Triple-Agonist Research

The triple-agonist pipeline: trial data, sourcing pathways, and safety coverage.

Head-to-Head Comparisons

Next-generation incretins against each other, with trial data.

Ozempic, Tirzepatide & Zepbound Guides

Practical guides for the approved medications people actually take.

Telehealth Program Comparisons

Legitimate prescription pathways reviewed: pricing, sourcing, and support.

GLP-1 Calculators

Free reconstitution and unit-conversion tools.

Current GLP-1 Offers We Track

Verified codes and auto-applied offers, checked against vendor pages.

Keep Researching

Our other topic hubs, each linking every page in its subject.

GLP-1 FAQ

The questions we hear most about this class.

Is retatrutide FDA-approved?

No. Retatrutide remains in clinical trials and is not FDA-approved. It is available through research vendors as a research-use-only compound, while approved GLP-1 medications like semaglutide and tirzepatide are available by prescription through licensed telehealth providers.

What is the strongest GLP-1 compound in trials?

Retatrutide has shown the largest weight-loss percentages in phase 2 trials (up to ~24% at 48 weeks), ahead of tirzepatide and semaglutide. CagriSema results are in a similar range. Trial efficacy does not translate to safety or availability outside studies.

Do I need a prescription for GLP-1 medications?

Yes. FDA-approved GLP-1 medications (Ozempic, Mounjaro, Zepbound, Wegovy) require a prescription, which telehealth programs can provide after a clinical review. Research-use-only compounds sold by peptide vendors are not prescription products and are not for human use.